T
42.60
-0.06 (-0.14%)
| Penutupan Terdahulu | 42.66 |
| Buka | 43.42 |
| Jumlah Dagangan | 2,248,180 |
| Purata Dagangan (3B) | 2,090,178 |
| Modal Pasaran | 3,961,497,600 |
| Harga / Pendapatan (P/E Ke hadapan) | 60.61 |
| Harga / Jualan (P/S) | 8.18 |
| Harga / Buku (P/B) | 36.17 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 4 May 2026 |
| Margin Keuntungan | -82.88% |
| Margin Operasi (TTM) | -52.21% |
| EPS Cair (TTM) | -2.78 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 97.50% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 1,220.07% |
| Nisbah Semasa (MRQ) | 2.05 |
| Aliran Tunai Operasi (OCF TTM) | -160.66 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -239.23 M |
| Pulangan Atas Aset (ROA TTM) | -23.21% |
| Pulangan Atas Ekuiti (ROE TTM) | -422.66% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Menaik | Bercampur |
| Biotechnology (Global) | Menaik | Bercampur | |
| Stok | Travere Therapeutics, Inc. | Menurun | Menurun |
AISkor Stockmoo
-1.0
| Konsensus Penganalisis | -2.0 |
| Aktiviti Orang Dalam | -1.5 |
| Volatiliti Harga | -0.5 |
| Purata Bergerak Teknikal | -5.0 |
| Osilator Teknikal | 4.0 |
| Purata | -1.00 |
|
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN) - rare kidney disorders that often cause end-stage kidney disease. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Growth |
| % Dimiliki oleh Orang Dalam | 0.75% |
| % Dimiliki oleh Institusi | 113.30% |
Tiada data dalam julat masa ini.
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| BAYNES ROY D. | - | 44.12 | -9,750 | -430,170 |
| Jumlah Keseluruhan Kuantiti Bersih | -9,750 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | -430,170 | |||
| Purata Pembelian Keseluruhan ($) | - | |||
| Purata Jualan Keseluruhan ($) | 44.12 | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| BAYNES ROY D. | Pengarah | 01 May 2026 | Jual automatik (-) | 9,750 | 44.12 | 430,170 |
| BAYNES ROY D. | Pengarah | 01 May 2026 | Pelaksanaan pilihan | 9,750 | - | - |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |